With the continuous innovation and major breakthroughs in life sciences and biotechnology, the global life sciences are thriving. At the same time, the integration of artificial intelligence, big data, and life sciences, coupled with breakthroughs in many fields such as genetic technology and stem cell technology, has brought unprecedented opportunities for the development of the life and health industry, and the “window†of the life science instrument market has opened. Recently, a recent research report from Research and Markets shows that the global life sciences instrument market is expected to be 54.49 billion US dollars in 2017, and the market is expected to reach 75.24 billion US dollars in 2022, and the compound annual growth rate during the forecast period is 6.7%. The life sciences include many subdivided fields such as molecular genetics, biochemistry, and cell biology. Among them, gene sequencing has become one of the hottest technologies in the field of life sciences in recent years; Stem cell therapeutic drugs are also booming and have been used in the clinical treatment of various diseases. At the same time, a series of important developments and major breakthroughs in biotechnology are accelerating the penetration into the field of application, adding to the development of the life sciences sector in China. In addition, the increasing prevalence of aging populations, chronic diseases, and other demographic changes in the population also drives demand for healthcare spending and life science products. Looking at the tide of development in the global life sciences, China has paid more attention to this field. Since 2016, China has made great progress in deepening medical reform. On December 21st, 2016, the State Council Executive Meeting adopted the “13th Five-Year Plan†for health and wellness planning and deployed the next five years to deepen the reform of the medical and health system; the Beijing-Tianjin-Hebei Sanitary Planning Commission jointly implemented medical imaging inspection data sharing for medical institutions. , between the 107 medical institutions such as Beijing Hospital and Union Hospital, 17 inspections can be mutual recognition. In 2017, health care reform remains a key area of ​​national concern. On June 7, the Ministry of Science and Technology, the Health and Planning Commission, the General Administration of Sport, the State Administration of Pharmaceutics and Drugs, the State Administration of Traditional Chinese Medicine, and the Logistics Department of the Central Military Commission jointly issued the “13th Five-Year Plan for Health and Health Technology Innovationâ€. On the "13th Five-Year Plan" health and health science and technology innovation put forward the current development, key tasks and safeguard measures. It is proposed to "strengthen innovation in the research and development of medical devices, promote the quality of medical devices, reduce import dependence, and reduce medical costs." At present, plans and opinions on medical device innovation and management are constantly being formulated and improved. With the rapid development of the life sciences, the demand for related instruments and equipment has increased significantly. Spectrometers, chromatographs, gene transfer devices, protein purification systems, cell fusion devices, electrophoresis, medical atomic absorption spectrometers, virus immunofluorescence analyzers, chromatographs, biochemical analyzers, etc. provide the latest in the life sciences industry. Technology and instrument support. At the same time, the current advances in medical science and technology, combined with the development of the medical field and artificial intelligence, have also promoted the development of innovation in the life sciences. Industry insiders expect that the next 20 to 30 years, the development of life sciences will usher in the golden period, and may even exceed the influence of the information industry. The great development trend of the industry will inevitably drive the development of the life science instrument industry. On this occasion, related companies in the field of life sciences in China should firmly grasp the business opportunities and seize the market first. Of course, the technological innovation and the upgrading of instrumentation and equipment are still fundamental to the occupation of the market. Therefore, in the era of artificial intelligence and big data, China still needs to further intensify research and development of technology and exploration and upgrade of life science instruments to enhance international competitiveness. . KNB1-32 Miniature Circuit Breaker
KNB1-32 Mini Circuit breakers, also named as the air switch which have a short for arc extinguishing device. It is a switch role, and also is a automatic protection of low-voltage electrical distribution. Its role is equivalent to the combination of switch. Fuse. Thermal Relay and other electrical components. It mainly used for short circuit and overload protection. Generally, According to the poles, mini Circuit breaker can be divided into 1P , 1P+N , 2P, 3P and 4P.
KNB1-32 Miniature Circuit Breaker,KNB1-32 Electronics Miniature Circuits Breaker,KNB1-32 Automatic Miniature Circuit Breaker,KNB1-32 Mini Circuit Breaker Wenzhou Korlen Electric Appliances Co., Ltd. , https://www.korlen-electric.com